{"id":"https://openalex.org/W3124600345","doi":"https://doi.org/10.1200/jco.2021.39.3_suppl.167","title":"Checkmate 577:Health-related quality of life (HRQoL) in a randomized, double-blind phase III study of nivolumab (NIVO) versus placebo (PBO) as adjuvant treatment in patients (pts) with resected esophageal or gastroesophageal junction cancer (EC/GEJC).","display_name":"Checkmate 577:Health-related quality of life (HRQoL) in a randomized, double-blind phase III study of nivolumab (NIVO) versus placebo (PBO) as adjuvant treatment in patients (pts) with resected esophageal or gastroesophageal junction cancer (EC/GEJC).","publication_year":2021,"publication_date":"2021-01-20","ids":{"openalex":"https://openalex.org/W3124600345","doi":"https://doi.org/10.1200/jco.2021.39.3_suppl.167","mag":"3124600345"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2021.39.3_suppl.167","doi":"https://doi.org/10.1200/jco.2021.39.3_suppl.167","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2021.39.3_suppl.167","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090645179","display_name":"Eric Van Cutsem","orcid":"https://orcid.org/0000-0002-6372-1230","observed_orcids":["https://orcid.org/0000-0002-6372-1230"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Eric Van Cutsem","raw_affiliation_strings":["University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium;","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059568847","display_name":"Prianka Singh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Prianka Singh","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ;","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018655814","display_name":"James M. Cleary","orcid":"https://orcid.org/0000-0001-7213-3951","observed_orcids":["https://orcid.org/0000-0001-7213-3951"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James M. Cleary","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059886787","display_name":"Ronan Joseph Kelly","orcid":"https://orcid.org/0000-0002-6446-2103","observed_orcids":["https://orcid.org/0000-0002-6446-2103"]},"institutions":[{"id":"https://openalex.org/I2802366037","display_name":"Baylor University Medical Center","ror":"https://ror.org/03nxfhe13","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802366037","https://openalex.org/I4210160418"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronan Joseph Kelly","raw_affiliation_strings":["The Charles A. Sammons Center at Baylor University Medical Center, Dallas, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Charles A. Sammons Center at Baylor University Medical Center, Dallas, TX;","institution_ids":["https://openalex.org/I2802366037"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038131926","display_name":"Markus Hermann Moehler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094062","display_name":"University Medical Center of the Johannes Gutenberg University Mainz","ror":"https://ror.org/00q1fsf04","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094062"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Markus H. Moehler","raw_affiliation_strings":["Johannes Gutenberg-University Clinic, Mainz, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johannes Gutenberg-University Clinic, Mainz, Germany;","institution_ids":["https://openalex.org/I4210094062"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040229584","display_name":"Jaros\u0142aw Ku\u017cd\u017ca\u0142","orcid":"https://orcid.org/0000-0002-8616-7519","observed_orcids":["https://orcid.org/0000-0002-8616-7519"]},"institutions":[{"id":"https://openalex.org/I126596746","display_name":"Jagiellonian University","ror":"https://ror.org/03bqmcz70","country_code":"PL","type":"education","lineage":["https://openalex.org/I126596746"]},{"id":"https://openalex.org/I4210102835","display_name":"John Paul II Hospital","ror":"https://ror.org/01apd5369","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210102835"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Jaroslaw Kuzdzal","raw_affiliation_strings":["Jagiellonian University, John Paul II Hospital, Cracow, Poland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jagiellonian University, John Paul II Hospital, Cracow, Poland;","institution_ids":["https://openalex.org/I126596746","https://openalex.org/I4210102835"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033459242","display_name":"Guillermo Ariel Mendez","orcid":"https://orcid.org/0000-0003-4675-6498","observed_orcids":["https://orcid.org/0000-0003-4675-6498"]},"institutions":[{"id":"https://openalex.org/I4210154782","display_name":"Favaloro Foundation","ror":"https://ror.org/053f3rt53","country_code":"AR","type":"facility","lineage":["https://openalex.org/I4210154782"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Guillermo Mendez","raw_affiliation_strings":["Fundacion Favaloro, Buenos Aires, Argentina;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fundacion Favaloro, Buenos Aires, Argentina;","institution_ids":["https://openalex.org/I4210154782"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087462672","display_name":"Satoru Motoyama","orcid":"https://orcid.org/0000-0001-9191-2563","observed_orcids":["https://orcid.org/0000-0001-9191-2563"]},"institutions":[{"id":"https://openalex.org/I4210132405","display_name":"Akita University Hospital","ror":"https://ror.org/02szmmq82","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210132405"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Satoru Motoyama","raw_affiliation_strings":["Akita University Hospital, Akita, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Akita University Hospital, Akita, Japan;","institution_ids":["https://openalex.org/I4210132405"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113167739","display_name":"Elena C. Elimova","orcid":"https://orcid.org/0009-0004-8299-7939","observed_orcids":["https://orcid.org/0009-0004-8299-7939"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Elena Elimova","raw_affiliation_strings":["Princess Margaret Cancer Centre, Toronto, ON, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Margaret Cancer Centre, Toronto, ON, Canada;","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057020836","display_name":"Cecile Grootscholten","orcid":"https://orcid.org/0000-0002-1896-5105","observed_orcids":["https://orcid.org/0000-0002-1896-5105"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Cecile Grootscholten","raw_affiliation_strings":["Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands;","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043432268","display_name":"Xiaowu Sun","orcid":"https://orcid.org/0000-0002-7960-4207","observed_orcids":["https://orcid.org/0000-0002-7960-4207","https://orcid.org/0000-0003-0274-8955"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaowu Sun","raw_affiliation_strings":["Adelphi Values, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adelphi Values, Boston, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086422682","display_name":"Fiona C. Taylor","orcid":"https://orcid.org/0000-0001-6474-4314","observed_orcids":["https://orcid.org/0000-0001-6474-4314"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fiona Taylor","raw_affiliation_strings":["Adelphi Values, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adelphi Values, Boston, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103245475","display_name":"Rachael M Lawrance","orcid":"https://orcid.org/0000-0002-9499-8443","observed_orcids":["https://orcid.org/0000-0002-9499-8443"]},"institutions":[{"id":"https://openalex.org/I4210091464","display_name":"Adelphi Group (United Kingdom)","ror":"https://ror.org/00egpfv87","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091464"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rachael Lawrance","raw_affiliation_strings":["Adelphi Values, Bollington, MA, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adelphi Values, Bollington, MA, United Kingdom;","institution_ids":["https://openalex.org/I4210091464"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112694052","display_name":"Brad Padilla","orcid":"https://orcid.org/0009-0006-1761-0034","observed_orcids":["https://orcid.org/0009-0006-1761-0034"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brad Padilla","raw_affiliation_strings":["Adelphi Values, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adelphi Values, Boston, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013401197","display_name":"Alejandro Moreno\u2010Koehler","orcid":"https://orcid.org/0000-0003-2463-1643","observed_orcids":["https://orcid.org/0000-0003-2463-1643"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alejandro Moreno-Koehler","raw_affiliation_strings":["Adelphi Values, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adelphi Values, Boston, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101989330","display_name":"Jenny Zhang","orcid":"https://orcid.org/0000-0003-0853-9978","observed_orcids":["https://orcid.org/0000-0003-0853-9978"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jenny Zhang","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ;","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066203287","display_name":"Steven I. Blum","orcid":"https://orcid.org/0000-0003-2438-9009","observed_orcids":["https://orcid.org/0000-0003-2438-9009"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven I. Blum","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ;","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044064524","display_name":"Jaffer A. Ajani","orcid":"https://orcid.org/0000-0001-9946-0629","observed_orcids":["https://orcid.org/0000-0001-9946-0629"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaffer A. Ajani","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":9,"institutions_distinct_count":13,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"39","issue":"3_suppl","first_page":"167","last_page":"167"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10619","display_name":"Esophageal Cancer Research and Treatment","score":0.9315999746322632,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10619","display_name":"Esophageal Cancer Research and Treatment","score":0.9315999746322632,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.035100001841783524,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.012000000104308128,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9020000100135803},{"id":"https://openalex.org/keywords/esophageal-cancer","display_name":"esophageal cancer","score":0.8270000219345093},{"id":"https://openalex.org/keywords/gastroesophageal-junction-cancer","display_name":"gastroesophageal junction cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/adjuvant-immunotherapy","display_name":"adjuvant immunotherapy","score":0.9150000214576721},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.984000027179718},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.9520000219345093},{"id":"https://openalex.org/keywords/fact-es","display_name":"FACT-ES","score":0.8059999942779541},{"id":"https://openalex.org/keywords/eq-5d-3l","display_name":"EQ-5D-3L","score":0.9449999928474426},{"id":"https://openalex.org/keywords/disease-related-symptoms","display_name":"disease-related symptoms","score":0.5289999842643738},{"id":"https://openalex.org/keywords/treatment-related-adverse-events","display_name":"treatment-related adverse events","score":0.5460000038146973},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.7139999866485596},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-related-pneumonitis","display_name":"immune-related pneumonitis","score":0.5429999828338623},{"id":"https://openalex.org/keywords/immune-mediated-colitis","display_name":"immune-related colitis","score":0.6970000267028809},{"id":"https://openalex.org/keywords/immune-related-dermatitis","display_name":"immune-related dermatitis","score":0.5889999866485596},{"id":"https://openalex.org/keywords/immune-related-endocrinopathy","display_name":"immune-related endocrinopathy","score":0.5730000138282776}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9337209463119507},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6367141008377075},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.588217556476593},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.5460715889930725},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.5194417834281921},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.49178603291511536},{"id":"https://openalex.org/C2779742542","wikidata":"https://www.wikidata.org/wiki/Q372701","display_name":"Esophageal cancer","level":3,"score":0.4759744703769684},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4223203659057617},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.35989367961883545},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3270387649536133},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.12590399384498596},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.06675264239311218},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.06653666496276855},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2021.39.3_suppl.167","doi":"https://doi.org/10.1200/jco.2021.39.3_suppl.167","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2021.39.3_suppl.167","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3169315270","https://openalex.org/W4206403705","https://openalex.org/W4386764738","https://openalex.org/W4200007880","https://openalex.org/W4410815151","https://openalex.org/W4393166279","https://openalex.org/W4414449071","https://openalex.org/W4317863105","https://openalex.org/W2763930264","https://openalex.org/W2604003845"],"abstract_inverted_index":{"167":[0],"Background:":[1],"NIVO":[2,34,61,143,158,258,286,314,334],"is":[3],"the":[4,49,95,138,194,236],"first":[5],"adjuvant":[6,333],"therapy":[7],"to":[8,105,134,157,326],"provide":[9],"a":[10,243,318],"statistically":[11],"significant":[12],"and":[13,68,74,81,99,132,144,175,224,259,268,273,295,330],"clinically":[14],"meaningful":[15],"improvement":[16,291],"in":[17,23,53,115,292,303,320,335],"disease-free":[18],"survival":[19],"(DFS)":[20],"versus":[21,62],"PBO":[22,63,145,163,260,307],"resected":[24,338],"EC/GEJC":[25,153],"following":[26],"neoadjuvant":[27],"chemoradiotherapy":[28],"as":[29],"demonstrated":[30,282],"by":[31],"CheckMate":[32,280],"577.":[33],"was":[35,77,121],"well":[36],"tolerated":[37],"with":[38,142,152,306,313,337],"an":[39],"acceptable":[40],"safety":[41],"profile.":[42],"This":[43],"analysis":[44],"provides":[45],"additional":[46],"information":[47],"on":[48,64,181,235,285],"exploratory":[50],"HRQoL":[51,186],"endpoints":[52],"this":[54],"clinical":[55,324],"trial.":[56],"Methods:":[57],"The":[58],"effect":[59],"of":[60,290],"HRQoL,":[65,321],"including":[66],"general":[67,296],"disease-related":[69],"symptoms,":[70],"functioning,":[71],"disease":[72],"burden,":[73],"overall":[75],"QoL,":[76],"assessed":[78,122],"using":[79,123],"FACT-E":[80,195,264],"EQ-5D-3L":[82],"patient-reported":[83],"outcome":[84],"(PRO)":[85],"questionnaires":[86],"administered":[87],"at":[88,100,173,178,249],"baseline":[89,248],"(BL),":[90],"every":[91],"4":[92],"weeks":[93],"during":[94],"12-month":[96],"treatment":[97,141,191,261,287,328],"period,":[98],"post-treatment":[101],"follow-up":[102],"visits":[103],"(up":[104],"2":[106],"years":[107],"after":[108],"last":[109],"dose).":[110],"Longitudinal":[111],"change":[112],"from":[113,247,279],"BL":[114,174,185],"PRO":[116,167],"scores":[117,187],"over":[118,308],"12":[119,179],"months":[120,180],"descriptive":[124],"statistics.":[125],"Additionally,":[126],"mixed":[127],"model":[128],"for":[129,193,245,256,263,332],"repeated":[130],"measures":[131],"time":[133,251],"deterioration":[135],"analyses":[136,241],"evaluated":[137],"difference":[139],"between":[140,190],"(data":[146],"not":[147,316],"shown).":[148],"Results:":[149],"794":[150],"pts":[151,284,304,336],"were":[154,170,188,300],"randomized":[155],"2:1":[156],"(n":[159,164],"=":[160,165],"532)":[161],"or":[162],"262).":[166],"completion":[168],"rates":[169],"\u2265":[171],"95%":[172],"~":[176],"90%":[177],"treatment.":[182],"Mean":[183],"(SD)":[184],"similar":[189],"arms":[192],"total":[196,265],"score":[197],"(NIVO:":[198,218,228],"133.40":[199],"[20.97];":[200],"PBO:":[201,211,221,231],"134.03":[202],"[20.40]);":[203],"esophageal":[204],"cancer":[205],"subscale":[206],"(ECS;":[207],"NIVO:":[208],"50.2":[209],"[9.3];":[210],"50.1":[212],"[8.9]);":[213],"EQ-5D":[214,225,269],"Visual":[215,270],"Analogue":[216,271],"Scale":[217,272],"70.4":[219],"[22.3];":[220],"69.1":[222],"[24.1]);":[223],"Utility":[226,274],"Index":[227],"0.820":[229],"[0.179];":[230],"0.831":[232],"[0.163])":[233],"based":[234],"UK":[237],"value":[238],"set.":[239],"Descriptive":[240],"showed":[242,288],"trend":[244],"increases":[246],"most":[250],"points":[252],"through":[253],"week":[254],"49":[255],"both":[257,293],"groups":[262],"score,":[266],"ECS,":[267],"Index.":[275],"Conclusions:":[276],"Preliminary":[277],"results":[278],"577":[281],"that":[283],"trends":[289,299],"esophageal-specific":[294],"HRQoL.":[297],"Similar":[298],"also":[301],"observed":[302],"treated":[305,312],"1":[309],"year.":[310],"Pts":[311],"did":[315],"experience":[317],"reduction":[319],"further":[322],"supporting":[323],"data":[325],"demonstrate":[327],"benefit":[329],"tolerability":[331],"EC/GEJC.":[339],"Clinical":[340],"trial":[341],"information:":[342],"NCT02743494.":[343]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2021-02-01T00:00:00"}